biosig_rgb.png
JACC: Clinical Electrophysiology Manuscript Featuring BioSig’s PURE EP System in Top Five Most Influential of 2016
21 févr. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Feb. 21, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies Donates to American Heart Association in Sponsorship of American Heart Month
10 févr. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Feb. 10, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
Cache Elite, Inc. Co
Cache Elite, Inc. Commences Audit for 2015 and 2016 Records
07 févr. 2017 16h30 HE | Cache Elite Inc.
SCOTTSDALE, Ariz., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Cache Elite, Inc. (OTC PINK:ILUS): On January 23rd, 2017, the Company’s Board of Directors approved and began the engagement of D. Brooks and...
biosig_rgb.png
BioSig Technologies Announces EU Institutional Investor Roadshow
30 janv. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 30, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies to Present at Monaco Growth Conference in Dubai, U.A.E.
25 janv. 2017 09h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 25, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
Cache Elite, Inc. (ILUS) Announces Review of 2016 & Corporate Vision for 2017 & Beyond
20 janv. 2017 13h08 HE | Cache Elite Inc.
SCOTTSDALE, Ariz., Jan. 20, 2017 (GLOBE NEWSWIRE) -- In 2016, Cache Elite, Inc. exceeded their goal in revenues, which will be released in the OTC Markets Quarterly in the upcoming weeks. These...
biosig_rgb.png
BioSig Technologies Issues Shareholder Letter
20 janv. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 20, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to...
biosig_rgb.png
BioSig Technologies’ PURE EP System Featured in The Journal of the American College of Cardiology: Clinical Electrophysiology
11 janv. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Jan. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary technology platform designed to improve the $4 billion...
TABB Group Forecasts
TABB Group Forecasts Continued Market Structure Changes for U.S. OTC Fixed Income Markets in 2017
21 déc. 2016 09h48 HE | TABB Group
NEW YORK and LONDON, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Though the U.S. corporate bond and U.S. treasury market has surged in size since the financial crisis in 2008, the unprecedented growth of U.S....
biosig_rgb.png
BioSig Technologies To Present Today At The Emerging Medical Technologies Summit
11 nov. 2016 07h15 HE | BioSig Technologies, Inc.
Minneapolis, MN, Nov. 11, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP)...